文摘
A practical synthesis of the peptide deformylase inhibitorLBM415, (2S)-N-(5-fluoro-1-oxido-2-pyridinyl)-1-[(2R)-2-[(formylhydroxyamino)methyl]-1-oxohexyl]-2-pyrrolidinecarboxamide,magnesium salt 11, is described. The key chiral intermediate,(2S)-N-(5-fluoro-2-pyridinyl)-1-[(2R)-2-[[formyl(phenylmethoxy)amino]methyl]-1-oxohexyl]-2-pyrrolidinecarboxamide 8, wasmade by coupling the corresponding amino acid 7 with thecarboxamide 25 prepared from L-proline and 2-amino-5-fluoropyridine. Following oxidation of the pyridine nitrogen,selective hydrogenolysis of the benzyl group afforded the freeacid of the drug substance, which was converted to themagnesium salt in situ with magnesium chloride. The productwas obtained in an overall yield of 16% with an ee > 99%.